ES2062990T3 - Vacunas, que contienen la proteina f del virus del sida. - Google Patents

Vacunas, que contienen la proteina f del virus del sida.

Info

Publication number
ES2062990T3
ES2062990T3 ES87401338T ES87401338T ES2062990T3 ES 2062990 T3 ES2062990 T3 ES 2062990T3 ES 87401338 T ES87401338 T ES 87401338T ES 87401338 T ES87401338 T ES 87401338T ES 2062990 T3 ES2062990 T3 ES 2062990T3
Authority
ES
Spain
Prior art keywords
vaccines
contain protein
aids
aids viruses
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87401338T
Other languages
English (en)
Inventor
Marie-Paule Kieny
Bruno Guy
Jean-Pierre Lecocq
Luc Montagnier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Institut Pasteur de Lille
Original Assignee
Transgene SA
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA, Institut Pasteur de Lille filed Critical Transgene SA
Application granted granted Critical
Publication of ES2062990T3 publication Critical patent/ES2062990T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

LA INVENCION SE REFIERE A UN VECTOR VIRICO CARACTERIZADO PORQUE INCLUYE AL MENOS: -UNA PARTE DEL GENOMA DE UN VIRUS; -UN GEN CODIFICANTE PARA LA PROTEINA F DEL VIRUS RESPONSABLE DEL SIDA, -ASI COMO LOE ELEMENTOS QUE ASEGURAN LA EXPRESION DE ESTA PROTEINA EN LAS CELULAS. ESTE VECTOR VIRICO PUEDE SER UTILIZADO COMO VACUNA EN EL TRATAMIENTO, LA PREVENCION Y EL DIAGNOSTICO DEL SIDA.
ES87401338T 1986-06-16 1987-06-15 Vacunas, que contienen la proteina f del virus del sida. Expired - Lifetime ES2062990T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8608698A FR2600079B1 (fr) 1986-06-16 1986-06-16 Vecteur viral et adn recombinant codant pour la proteine f du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la proteine, proteine obtenue, vaccin et anticorps obtenus

Publications (1)

Publication Number Publication Date
ES2062990T3 true ES2062990T3 (es) 1995-01-01

Family

ID=9336386

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87401338T Expired - Lifetime ES2062990T3 (es) 1986-06-16 1987-06-15 Vacunas, que contienen la proteina f del virus del sida.

Country Status (11)

Country Link
EP (1) EP0253693B1 (es)
JP (1) JPH01500962A (es)
KR (1) KR880701285A (es)
AT (1) ATE103980T1 (es)
AU (1) AU614934B2 (es)
DE (1) DE3789525T2 (es)
DK (1) DK76688D0 (es)
ES (1) ES2062990T3 (es)
FR (1) FR2600079B1 (es)
PT (1) PT85093B (es)
WO (1) WO1987007642A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2615623B1 (fr) * 1987-05-22 1992-06-19 Transgene Sa Test de diagnostic du sida base sur la mise en evidence d'une diversite de la reponse isotypique, vaccins et serotherapies
FR2620030B1 (fr) * 1987-09-07 1990-03-23 Transgene Sa Vecteur d'expression des proteines du virus hiv-2, un agent causal du sida, culture cellulaire infectee ou transformee par ce vecteur, proteines obtenues, vaccin et anticorps obtenus
FR2629459B1 (fr) * 1988-04-01 1990-12-21 Pasteur Institut Peptides pf11 a pf19 d'un retrovirus hiv - procede de synthese de ces peptides - leur utilisation notamment pour le diagnostic
JPH03503639A (ja) * 1988-04-01 1991-08-15 アンステイテユ・パストウール レトロウイルスｈｉｖのペプチドｐｆ１０〜ｐｆ１９、該ペプチドの合成方法、特に診断用としてのその使用
FR2629460B1 (fr) * 1988-04-01 1990-12-21 Pasteur Institut Peptides pf16 d'un retrovirus hiv - procede de synthese de ces peptides - leur utilisation pour le diagnostic
US5221610A (en) * 1988-05-26 1993-06-22 Institut Pasteur Diagnostic method and composition for early detection of HIV infection
EP0485611B1 (en) * 1990-05-28 1999-03-17 The Research Foundation For Microbial Diseases Of Osaka University Method of preparing plasmid having capabilities of expressing and processing after translation of retrovirus gene, plasmid obtained thereby and product of expression thereof
FR2766091A1 (fr) * 1997-07-18 1999-01-22 Transgene Sa Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee

Also Published As

Publication number Publication date
EP0253693A1 (fr) 1988-01-20
DK76688A (da) 1988-02-15
KR880701285A (ko) 1988-07-26
ATE103980T1 (de) 1994-04-15
EP0253693B1 (fr) 1994-04-06
AU7514087A (en) 1988-01-11
DE3789525D1 (de) 1994-05-11
FR2600079A1 (fr) 1987-12-18
PT85093B (pt) 1990-03-30
JPH01500962A (ja) 1989-04-06
AU614934B2 (en) 1991-09-19
PT85093A (fr) 1987-07-01
DE3789525T2 (de) 1994-08-25
FR2600079B1 (fr) 1989-10-20
WO1987007642A1 (fr) 1987-12-17
DK76688D0 (da) 1988-02-15

Similar Documents

Publication Publication Date Title
ES2194029T3 (es) Variantes del virus hiv-2.
ES2061708T3 (es) Virus recombinante de la viruela de la gallina, vectores de expresion de proteinas heterologas y vacunas para aves de corral derivadas de este virus.
CA2243570A1 (en) Mixture of recombinant vaccinia vectors as polyenv vaccines for hiv
ATE229978T1 (de) Helicobacter proteine und impstoffe
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
DE69936337D1 (de) Verfahren zur entwicklung von einem hiv impfstoff
ATE103328T1 (de) Fuer ein glykoprotein des aids-virus kodierende virus-vektoren, vakzin und antikoerper.
TW377373B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
ES2062990T3 (es) Vacunas, que contienen la proteina f del virus del sida.
ES2113910T3 (es) Procedimiento para la preparacion de un concentrado de trombina asegurado contra virus.
DK8789A (da) Fremgangsmaade til fremstilling af modificerede, staerkt afsvaekkede rna-virusstammer samt vaccine og dens anvendelse
DK498387A (da) Virus-dna-sekvens
DK631387D0 (da) Virusvektor
ATE107695T1 (de) Virusvektor und rekombinante dns, die ein oder mehrere strukturelle proteine (ha,f und/oder np) eines morbillivirus kodieren.
DK135588A (da) Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler
ES507444A0 (es) Procedimiento para inactivar virus de la fiebre aftosa.
ES2084587T3 (es) Arn virus no revertientes.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 253693

Country of ref document: ES